Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 8,533 | 5,785 | 0 | 0 | 0 |
Gross Profit | 8,533 | 5,785 | N/A | N/A | N/A |
Operating Expenses | 20,736 | 16,514 | 19,714 | 15,048 | 17,488 |
Operating Income | -12,203 | -10,729 | -12,551 | -15,048 | -17,488 |
Other Income | 1,457 | 1,652 | 1,622 | 628 | 592 |
Pre-tax Income | -10,746 | -9,077 | -10,929 | -14,420 | -16,896 |
Income Tax | 406 | N/A | N/A | N/A | N/A |
Net Income Continuous | -11,152 | -9,077 | -10,962 | -14,420 | -16,896 |
Net Income | $-11,152 | $-9,077 | $-10,962 | $-14,420 | $-16,896 |
EPS Basic Total Ops | -1.98 | -1.66 | -1.80 | -3.24 | -3.88 |
EPS Basic Continuous Ops | -1.98 | -1.66 | -1.75 | -3.29 | -3.88 |
EPS Diluted Total Ops | -1.98 | -1.66 | -1.80 | -3.24 | -3.88 |
EPS Diluted Continuous Ops | -1.98 | -1.66 | -1.75 | -3.29 | -3.88 |
EPS Diluted Before Non-Recurring Items | -1.98 | -1.66 | N/A | -3.24 | -3.84 |
EBITDA(a) | $-13,131 | $-11,961 | $-20,681 | $-15,245 | $-17,531 |